Velusetrag
Velusetrag (also known as TD-5108) is a serotonin receptor agonist developed by Theravance Biopharma for the treatment of gastrointestinal disorders. It is currently in clinical trials for the treatment of gastroparesis and chronic constipation.
History[edit | edit source]
Velusetrag was initially developed by Theravance Biopharma, a biopharmaceutical company focused on the creation of small molecule medicines. The drug is currently in the late stages of clinical trials.
Mechanism of Action[edit | edit source]
Velusetrag works by stimulating the 5-HT4 receptor, a type of serotonin receptor found in the gastrointestinal tract. This stimulation increases the movement of the intestines, helping to speed up the passage of food through the stomach.
Clinical Trials[edit | edit source]
Velusetrag has undergone several clinical trials for the treatment of gastroparesis and chronic constipation. In a Phase 2 trial, the drug was found to significantly improve gastric emptying and symptoms in patients with gastroparesis. A Phase 3 trial is currently underway.
Side Effects[edit | edit source]
Common side effects of Velusetrag include nausea, diarrhea, and headache. In clinical trials, these side effects were generally mild to moderate in severity.
Future Developments[edit | edit source]
If successful in clinical trials, Velusetrag could provide a new treatment option for patients with gastroparesis and chronic constipation, conditions for which there are currently limited treatment options.
Velusetrag Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD